Fintel reports that on April 4, 2025, Citigroup upgraded their outlook for Eastman Chemical (NYSE:EMN) from Neutral to Buy.
Analyst Price Forecast Suggests 45.40% Upside
As of April 2, 2025, the average one-year price target for Eastman Chemical is $116.29/share. The forecasts range from a low of $104.03 to a high of $134.40. The average price target represents an increase of 45.40% from its latest reported closing price of $79.98 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Eastman Chemical is 10,278MM, an increase of 9.55%. The projected annual non-GAAP EPS is 9.96.
What is the Fund Sentiment?
There are 1,413 funds or institutions reporting positions in Eastman Chemical. This is an increase of 20 owner(s) or 1.44% in the last quarter. Average portfolio weight of all funds dedicated to EMN is 0.16%, an increase of 3.41%. Total shares owned by institutions increased in the last three months by 6.40% to 129,665K shares. 
The put/call ratio of EMN is 0.23, indicating a bullish outlook.
What are Other Shareholders Doing?
Capital Research Global Investors holds 5,887K shares representing 5.10% ownership of the company. In its prior filing, the firm reported owning 5,189K shares , representing an increase of 11.85%. The firm decreased its portfolio allocation in EMN by 8.46% over the last quarter.
Franklin Resources holds 5,785K shares representing 5.01% ownership of the company. In its prior filing, the firm reported owning 5,219K shares , representing an increase of 9.78%. The firm decreased its portfolio allocation in EMN by 84.92% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 3,635K shares representing 3.15% ownership of the company. In its prior filing, the firm reported owning 3,717K shares , representing a decrease of 2.25%. The firm decreased its portfolio allocation in EMN by 21.38% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 3,137K shares representing 2.72% ownership of the company. In its prior filing, the firm reported owning 3,062K shares , representing an increase of 2.41%. The firm decreased its portfolio allocation in EMN by 20.92% over the last quarter.
NAESX - Vanguard Small-Cap Index Fund Investor Shares holds 2,952K shares representing 2.56% ownership of the company. In its prior filing, the firm reported owning 2,926K shares , representing an increase of 0.90%. The firm decreased its portfolio allocation in EMN by 19.60% over the last quarter.
Eastman Chemical Background Information
(This description is provided by the company.)
Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company's innovation-driven growth model takes advantage of world- class technology platforms, deep customer engagement, and differentiated application development to grow its leading positions in attractive end-markets such as transportation, building and construction, and consumables. As a globally inclusive and diverse company, Eastman employs approximately 14,500 people around the world and serves customers in more than 100 countries. The company had 2019 revenues of approximately $9.3 billion and is headquartered in Kingsport, Tennessee, USA.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
